The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial

BACKGROUND: Melasma is a common acquired symmetrical hypermelanosis that occurs on sun-exposed areas, and it is frequently observed among women. Various treatment modalities have been tried, but none are completely satisfactory. 4-n-butylresorcinol, which is a resorcinol derivative that has an inhib...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Huh, Sun Young, Shin, Jung-Won, Na, Jung-Im, Huh, Chang-Hun, Youn, Sang-Woong, Park, Kyoung-Chan
Format: Artigo
Jezik:Inglês
Izdano: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2883392/
https://ncbi.nlm.nih.gov/pubmed/20548876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2010.22.1.21
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items